Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Q3 2025 value amounting to $387.7 million.

  • Amphastar Pharmaceuticals' Treasury Shares rose 3332.54% to $387.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $387.7 million, marking a year-over-year increase of 3332.54%. This contributed to the annual value of $332.7 million for FY2024, which is 3446.74% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Treasury Shares stood at -$15.3 million for Q3 2025, which was down 2445.25% from -$15.2 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Treasury Shares high stood at $1.3 million for Q3 2023, and its period low was -$15.3 million during Q3 2025.
  • Its 5-year average for Treasury Shares is -$6.2 million, with a median of -$8.7 million in 2021.
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 1476.09% in 2021, then surged by 4966.67% in 2025.
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Treasury Shares stood at $150.5 million in 2021, then increased by 25.95% to $189.5 million in 2022, then skyrocketed by 30.55% to $247.4 million in 2023, then soared by 34.47% to $332.7 million in 2024, then increased by 16.51% to $387.7 million in 2025.
  • Its Treasury Shares was $387.7 million in Q3 2025, compared to $382.8 million in Q2 2025 and $343.9 million in Q1 2025.